Prenetics company will explore digital asset adoption and Bitcoin financial strategy

Golden Finance reported that Nasdaq listed company Prenetics announced the transfer of its ownership of ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for $71.78 million, resulting in a cash reserve of approximately $86 million and an estimated cash and short-term assets of $117 million. The company maintains a debt free balance sheet with zero liabilities, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies.